The metabolic pattern of VPA in 170 epileptic patients without symptoms or signs of hepatic side effects was compared to that in 11 patients with early symptoms and signs of hepatotoxicity and in 5 children with fulminant liver failure. A cohort of 470 patients in whom VPA serum metabolites had been measured were examined at several pediatric epilepsy clinics between 1986 and 1991 and results were evaluated at the Departments of Pediatrics, RittbergKrankenhaus; and Free University, Berlin, Germany; and University Hospital, Bern, Switzerland. In the reference group, infants receiving VPA monotherapy and comedication with other AEDs showed lower concentrations of the potential hepatotoxin 4-ene-VPA than did older children. Three of 4 children who died had massive lactic acidosis. In all children with probable VPA-associated hepatotoxicity, VPA metabolic patterns were different from the reference group, but were not specific or distinct, even in those who died. Increased values of 4-ene-VPA were found in only 1 of the 5 children with fulminant liver failure. 
children who died had massive lactic acidosis. In all children with probable VPA-associated hepatotoxicity, VPA metabolic patterns were different from the reference group, but were not specific or distinct, even in those who died. COMMENT. Avoid drug combination and limit fluids with desmopressin.
